Viewing Study NCT00772668


Ignite Creation Date: 2025-12-24 @ 5:49 PM
Ignite Modification Date: 2026-01-02 @ 11:47 AM
Study NCT ID: NCT00772668
Status: TERMINATED
Last Update Posted: 2017-12-11
First Post: 2008-10-12
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Rituximab, Cyclophosphamide, Bortezomib, and Prednisone in Patients With Stage III/IV FL or MZL
Sponsor: University of Miami
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lymphoma View
None Follicular Lymphoma View
None Marginal Zone Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None stage III grade 1 follicular lymphoma View
None stage IV grade 1 follicular lymphoma View
None stage III grade 2 follicular lymphoma View
None stage IV grade 2 follicular lymphoma View
None stage III marginal zone lymphoma View
None stage IV marginal zone lymphoma View